L’arrivée de l’immunothérapie dans le lymphome de Hodgkin
Sign Up to like & getrecommendations! Published in 2018 at "Bulletin du cancer"
DOI: 10.1016/s0007-4551(18)30390-4
Abstract: IMMUNOTHERAPY OF HODGKIN LYMPHOMA Classical Hodgkin lymphoma (HL) is a rare hematological cancer, affecting preferentially young adults. Using a risk-adapted approach, HL has become highly curable (>80%) with front-line chemotherapy in addition with radiotherapy, despite… read more here.
Keywords: rapie dans; immunoth rapie; dans lymphome; lymphome hodgkin ... See more keywords